quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:13:49·875d
NEWSRelease
BioCryst Pharmaceuticals Inc. logo
Baudax Bio Inc. logo

CORRECTION: BioCryst Pharmaceuticals Ticker is "BCRX

BCRX· BioCryst Pharmaceuticals Inc.BXRX· Baudax Bio Inc.
Health Care
Original source

Companies

  • BCRX
    BioCryst Pharmaceuticals Inc.
    Health Care
  • BXRX
    Baudax Bio Inc.
    Health Care

Recent analyst ratings

  • Feb 18BCRXUpdateEvercore ISI$17.00
  • Oct 15BCRXUpdateTD Cowen$30.00
  • Oct 1BCRXUpdateEvercore ISI$8.00
  • Apr 29BCRXUpdateCantor Fitzgerald$20.00
  • Feb 25BCRXUpdateWedbush$15.00
  • Nov 20BCRXUpdateJP Morgan$10.00

Related

  • SEC15h
    SEC Form DEFA14A filed by BioCryst Pharmaceuticals Inc.
  • SEC15h
    SEC Form DEF 14A filed by BioCryst Pharmaceuticals Inc.
  • PR9d
    BioCryst to Report First Quarter 2026 Financial Results on May 6
  • INSIDER16d
    SEC Form 4 filed by Menon Sandeep
  • INSIDER16d
    SEC Form 3 filed by new insider Menon Sandeep
  • PR18d
    BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
  • PR21d
    BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by BioCryst Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022